Interleukin-1 is associated with inflammation and structural lung disease in young children with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 17, Issue 6, 2018, Pages 715-722

  Montgomery, Samuel T ^a   Dittrich, A Susanne ^b,c   Garratt, Luke W ^d   Turkovic, Lidija ^d   Frey, Dario L ^b,c   Stick, Stephen M ^a,d,e,f   Mall, Marcus A ^b,g,h   Kicic, Anthony ^a,d,e,f,i  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h BERLIN INSTITUTE OF HEALTH   (Germany)

ⁱ CURTIN UNIVERSITY   (Australia)

^j MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^k UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

Airway epithelium; Cystic fibrosis; Hypoxia; Interleukin (IL) 1; Mucus; Neutrophilic inflammation

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 8; LEUKOCYTE ELASTASE;

ARTICLE; BACTERIAL INFECTION; BRONCHOALVEOLAR LAVAGE FLUID; CHILD; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HUMAN; INFANT; LEUKOCYTE DIFFERENTIAL COUNT; LUNG DEVELOPMENT; LUNG DISEASE; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT INFLAMMATION; SIGNAL TRANSDUCTION; X-RAY COMPUTED TOMOGRAPHY; DIAGNOSTIC IMAGING; ENZYMOLOGY; IMMUNOLOGY; INFLAMMATION; LUNG; METABOLISM; PATHOLOGY; PRESCHOOL CHILD; PROCEDURES;

BRONCHOALVEOLAR LAVAGE FLUID; CHILD, PRESCHOOL; CORRELATION OF DATA; CYSTIC FIBROSIS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1ALPHA; LEUKOCYTE ELASTASE; LUNG; MALE; NEUTROPHILS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85048575106     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2018.05.006     Document Type: Article

References (28)

1. Sly, P.D., Brennan, S., Gangell, C., et al. Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med 180:2 (2009), 146–152.
2. Stick, S.M., Brennan, S., Murray, C., et al. Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr, 155(5), 2009, 623-8 e1.
3. Sly, P.D., Gangell, C.L., Chen, L., et al. Risk factors for bronchiectasis in children with cystic fibrosis. N Engl J Med 368:21 (2013), 1963–1970.
4. Wielputz, M.O., Puderbach, M., Kopp-Schneider, A., et al. Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease. Am J Respir Crit Care Med 189:8 (2014), 956–965.
5. Mall, M., Grubb, B.R., Harkema, J.R., et al. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. Nat Med 10:5 (2004), 487–493.
6. Livraghi-Butrico, A., Kelly, E.J., Klem, E.R., et al. Mucus clearance, MyD88-dependent and MyD88-independent immunity modulate lung susceptibility to spontaneous bacterial infection and inflammation. Mucosal Immunol 5:4 (2012), 397–408.
7. Zhou-Suckow, Z., Duerr, J., Hagner, M., et al. Airway mucus, inflammation and remodeling: emerging links in the pathogenesis of chronic lung diseases. Cell Tissue Res 367:3 (2017), 537–550.
8. Fritzsching, B., Zhou-Suckow, Z., Trojanek, J.B., et al. Hypoxic epithelial necrosis triggers neutrophilic inflammation via IL-1 receptor signaling in cystic fibrosis lung disease. Am J Respir Crit Care Med 191:8 (2015), 902–913.
9. Armstrong, D.S., Hook, S.M., Jamsen, K.M., et al. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Pediatr Pulmonol 40:6 (2005), 500–510.
10. Brennan, S., Hall, G.L., Horak, F., et al. Correlation of forced oscillation technique in preschool children with cystic fibrosis with pulmonary inflammation. Thorax 60:2 (2005), 159–163.
11. Garratt, L.W., Sutanto, E.N., Ling, K.M., et al. Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis. Eur Respir J 46:2 (2015), 384–394.
12. Rosenow, T., Oudraad, M.C., Murray, C.P., et al. PRAGMA-CF. a quantitative structural lung disease computed tomography outcome in young children with cystic fibrosis. Am J Respir Crit Care Med 191:10 (2015), 1158–1165.
13. Gehrig, S., Duerr, J., Weitnauer, M., et al. Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung disease. Am J Respir Crit Care Med 189:9 (2014), 1082–1092.
14. Chen, C.J., Kono, H., Golenbock, D., et al. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 13:7 (2007), 851–856.
15. Montgomery, S.T., Mall, M.A., Kicic, A., et al. Hypoxia and sterile inflammation in cystic fibrosis airways: mechanisms and potential therapies. Eur Respir J, 49(1), 2017.
16. Zhou, Z., Duerr, J., Johannesson, B., et al. The enac-overexpressing mouse as a model of cystic fibrosis lung disease. J Cyst Fibros 10:Suppl. 2 (2011), S172–S182.
17. Mall, M.A., Harkema, J.R., Trojanek, J.B., et al. Development of chronic bronchitis and emphysema in beta-epithelial Na+ channel-overexpressing mice. Am J Respir Crit Care Med 177:7 (2008), 730–742.
18. Johannesson, B., Hirtz, S., Schatterny, J., et al. CFTR regulates early pathogenesis of chronic obstructive lung disease in βENaC-overexpressing mice. PLoS One, 7(8), 2012, e44059.
19. Zhou, Z., Treis, D., Schubert, S.C., et al. Preventive but not late amiloride therapy reduces morbidity and mortality of lung disease in betaenac-overexpressing mice. Am J Respir Crit Care Med 178:12 (2008), 1245–1256.
20. Iyer, S.S., Pulskens, W.P., Sadler, J.J., et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci U S A 106:48 (2009), 20388–20393.
21. Fettelschoss, A., Kistowska, M., LeibundGut-Landmann, S., et al. Inflammasome activation and IL-1beta target IL-1alpha for secretion as opposed to surface expression. Proc Natl Acad Sci U S A 108:44 (2011), 18055–18060.
22. 2+-dependent Nlrp3 activation exacerbates the pseudomonas aeruginosa-driven inflammatory response in cystic fibrosis. Nat Commun, 6, 2015, 6201.
23. Kim, S.R., Kim, D.I., Kim, S.H., et al. Nlrp3 inflammasome activation by mitochondrial ros in bronchial epithelial cells is required for allergic inflammation. Cell Death Dis, 5(10), 2014, e1498.
24. Cullen, S.P., Kearney, C.J., Clancy, D.M., et al. Diverse activators of the Nlrp3 inflammasome promote IL-1beta secretion by triggering necrosis. Cell Rep 11:10 (2015), 1535–1548.
25. Stahl, M., Wielputz, M.O., Graeber, S.Y., et al. Comparison of lung clearance index and magnetic resonance imaging for assessment of lung disease in children with cystic fibrosis. Am J Respir Crit Care Med 195:3 (2017), 349–359.
26. Mall, M.A., Stahl, M., Graeber, S.Y., et al. Early detection and sensitive monitoring of cf lung disease: prospects of improved and safer imaging. Pediatr Pulmonol 51:S44 (2016), S49–s60.
27. Iannitti, R.G., Napolioni, V., Oikonomou, V., et al. IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis. Nat Commun, 7, 2016, 10791.
28. Bresnihan, B., Alvaro-Gracia, J.M., Cobby, M., et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 41:12 (1998), 2196–2204.